Literature DB >> 31352654

Procalcitonin in hemodialysis patients presenting with fever or chills to the emergency department.

R Schneider1, M J Cohen2, S Benenson3, O Duchin1, Y S Haviv4, M Elhalel-Darnitski1, P D Levin5.   

Abstract

We sought to assess the role of procalcitonin in discriminating severe bacterial infections requiring antibiotic treatment from non-bacterial causes of fever or chills in chronic dialysis patients. Chronic hemodialysis patients who were admitted to the emergency room due to fever and/or chills were recruited to the study. The presence or absence of bacterial infection was defined after recruitment conclusion by an infectious disease specialist who was blinded to procalcitonin results. Procalcitonin levels were compared between infected and non-infected patients. Out of 54 patients recruited, 22 (41%) patients eventually diagnosed with infection. Mean (± SD) procalcitonin values were 4.3 (± 5.5) ng/ml among cases, 1.0 (± 2.0) ng/ml among controls with no infection (p = 0.02). A cutoff PCT value of 1 ng/ml or higher had 77% sensitivity and 59% specificity for the diagnosis of severe infection. Procalcitonin cannot usefully identify hemodialysis patient with bacterial infection.

Entities:  

Keywords:  Bacterial infection; Hemodialysis; Procalcitonin

Mesh:

Substances:

Year:  2019        PMID: 31352654     DOI: 10.1007/s11739-019-02156-7

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN: 1828-0447            Impact factor:   3.397


  22 in total

1.  Clinical experiences with a new semi-quantitative solid phase immunoassay for rapid measurement of procalcitonin.

Authors:  M Meisner; F M Brunkhorst; H B Reith; J Schmidt; H G Lestin; K Reinhart
Journal:  Clin Chem Lab Med       Date:  2000-10       Impact factor: 3.694

2.  Procalcitonin: diagnostic value in systemic infections in chronic kidney disease or renal transplant patients.

Authors:  Raluca Dumea; Dimitrie Siriopol; Simona Hogas; Irina Mititiuc; Adrian Covic
Journal:  Int Urol Nephrol       Date:  2013-08-30       Impact factor: 2.370

3.  Procalcitonin as an early predictor of acute infection in hemodialysis patients.

Authors:  Borja Quiroga; Maite Villaverde; Almudena Vega; Soraya Abad; Javier Reque; Juan M López-Gómez
Journal:  Nefrologia       Date:  2014-05-21       Impact factor: 2.033

Review 4.  Management of the dialysis patient in general intensive care.

Authors:  N Arulkumaran; R M Montero; M Singer
Journal:  Br J Anaesth       Date:  2012-01-04       Impact factor: 9.166

5.  Usefulness of procalcitonin for diagnosis of infective endocarditis.

Authors:  Matjaz Jereb; Tadeja Kotar; Tomaz Jurca; Tatjana Lejko Zupanc
Journal:  Intern Emerg Med       Date:  2009-04-09       Impact factor: 3.397

6.  Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial.

Authors:  Lila Bouadma; Charles-Edouard Luyt; Florence Tubach; Christophe Cracco; Antonio Alvarez; Carole Schwebel; Frédérique Schortgen; Sigismond Lasocki; Benoît Veber; Monique Dehoux; Maguy Bernard; Blandine Pasquet; Bernard Régnier; Christian Brun-Buisson; Jean Chastre; Michel Wolff
Journal:  Lancet       Date:  2010-01-25       Impact factor: 79.321

7.  Role of procalcitonin in the diagnosis of infective endocarditis: a meta-analysis.

Authors:  Chin-Wei Yu; Ling-I Juan; Shou-Chien Hsu; Chun-Kuei Chen; Chun-Wei Wu; Chien-Chang Lee; Jiunn-Yih Wu
Journal:  Am J Emerg Med       Date:  2013-04-17       Impact factor: 2.469

8.  Procalcitonin values after dialysis is closely related to type of dialysis membrane.

Authors:  Martina Montagnana; Giuseppe Lippi; Nicola Tessitore; Gian Luca Salvagno; Elisa Danese; Giovanni Targher; Antonio Lupo; Gian Cesare Guidi
Journal:  Scand J Clin Lab Invest       Date:  2009       Impact factor: 1.713

9.  WINPEPI (PEPI-for-Windows): computer programs for epidemiologists.

Authors:  Joseph H Abramson
Journal:  Epidemiol Perspect Innov       Date:  2004-12-17

10.  Sensitivity and specificity of procalcitonin in predicting bacterial infections in patients with renal impairment.

Authors:  Dena El-Sayed; Jonathan Grotts; William A Golgert; Alan M Sugar
Journal:  Open Forum Infect Dis       Date:  2014-08-21       Impact factor: 3.835

View more
  4 in total

1.  Interpreting procalcitonin in patients undergoing hemodialysis: a reliable or a misleading marker?

Authors:  Marco Falcone; Giusy Tiseo; Francesco Menichetti
Journal:  Intern Emerg Med       Date:  2020-05-02       Impact factor: 3.397

Review 2.  [Procalcitonin in the intensive care unit : Differential diagnostic and differential therapeutic possibilities].

Authors:  S Großmann; S Schroll; M Pfeifer
Journal:  Med Klin Intensivmed Notfmed       Date:  2020-06-29       Impact factor: 0.840

3.  Assessment of mechanisms of infectious pneumonia based on expression of fibrinogen, procalcitonin, high-sensitivity C-reactive protein expression, T helper 17 cells, regulatory T cells interleukin-10, and interleukin-17.

Authors:  Dao-Ming Zu; Lei Zhang
Journal:  Transl Pediatr       Date:  2022-01

4.  Diagnostic value of procalcitonin for bacterial infections in patients undergoing hemodialysis: a systematic review and meta-analysis.

Authors:  Mei Tao; Danna Zheng; Xudong Liang; Qiang He; Wei Zhang
Journal:  Ren Fail       Date:  2022-12       Impact factor: 2.606

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.